Drugs Flashcards
DMARDs
RA
Disease modifying anti-rheumatic drugs
immunosuppressive agents with goal of inducing/maintaining remission - all oral
methotrexate, leflunomide, sulfasalazine, hydroxychloroquine, azathiopurine
“My Lucky Sister Has Arthritis”
Biologics
RA
newer, made by molecular biologic techniques
targets cytokines, T cell activation and depletion of B cells
Anakinra, TNF inhibitors (etanercept, adalimumab, certolizumab, golimumab, infliximab), Abatacept, Tocilizumab, Tofacitinib, Rituximab
ATATTR (ATT totally rules)
TNF inhibitors
RA
pro-inflammatory cytokine
produced by macrophages
reduces joint inflammation and damage to joints
Etanercept (Enbrel): subcutaneous; binds TNF and blocks its interaction with receptors
Adalimumab (Humira): subcutaneous; human monoclonal antibody directed against TNF
Certolizumab (Cimzia): subcutaneous; Fab fragment of a humanized monoclonal antibody directed against TNF
Golimumab (Simponi): subcutaneous; human monoclonal antibody directed against TNF
Infliximab (Remicade): infusion; chimeric monoclonal antibody directed against TNF
methotrexate
first line treatment; give folic acid to prevent side effects
RA
increases adenosine release from cells which can dampen cellular inflammation
inhibits dihydrofolate reductase (why need to give folate)
side effects: oral ulcers, nausea, cytopenias, liver toxicity
NOT FOR PREG. WOMEN -> induces abortions
dose: 15-25mg/week
leflunomide
RA
inhibits pyrimidine synthesis which leads to reduction of lymphocytes
is a pro-drug; enterohepatocyte circulation leads to long half life
side effects: diarrhea, cytopenias, liver toxicity
DO NOT GIVE TO PREG WOMEN
sulfasalazine
RA
sulfapyridine is active moiety; mechanism of action not known
side effects: rash, GI upset, hepatotoxicity, cytopenias
hydroxychloroquine
RA
mildest; also used for SLE
inhibits activity of TLRs and acidification of lysosomes ultimately interfering with antigen processing
side effects: rare retinal toxicity
azathiopurine
RA
pruine synthesis inhibitor
not often used due to side effects: cytopenias, rash, GI upset, pancreatitis
Etanercept (Enbrel)
RA
subcutaneous; binds TNF and blocks its interaction with receptors - is a fusion protein of TNF receptor linked to Fc portion of IgG
The only TNF that is not a monoclonal antibody
Adalimumab (Humira)
RA
subcutaneous; human monoclonal antibody directed against TNF
Certolizumab (Cimzia)
RA
subcutaneous; Fab fragment of a humanized monoclonal antibody directed against TNF
Golimumab (Simponi)
RA
subcutaneous; human monoclonal antibody directed against TNF
Infliximab (Remicade)
RA
infusion; chimeric monoclonal antibody directed against TNF
Anakinra
RA
antagonist of IL-1 receptor
does not work very well but is FDA approved
Abatacept
RA
Binds CD90/86 on APCs blocking the interaction of CD28 between APCs and T cells
blocks the costimulation of T cells -> blocks T cell activation which are the center cells of pathogenesis
prevents joint damage and inflammation; short and long term benefits
Tocilizumab
RA
humanized monoclonal antibody targeting IL-6 receptor
reduces inflammation and joint damage -> helps to prevent natural history of RA
Rituximab
RA
monoclonal antibody directed against CD20 antigen on B lymphocytes -> depletes B cells but NOT existing plasma cells
also works for B cell cancers
Tofacitinib
RA
inhibits JAK enzymes, which prevents cytokine/growth factor mediated gene expression and intracellular activity of immune cells
target synthetic DMARD
oral
totally different pathway that is early in the disease pathogenesis
triple therapy
for RA: methotrexate, sulfasalazine, hydroxychloroquine
NSAIDs vs Glucocorticoids
NSAIDs: block cyclooxygenase (COX)…very specific
GC: block phospholipase A2 (PLA2) and some can affect COX
what is the molecular path to inflammation?
phospholipids (cell membrane) —- phospholipase A2 (PLA2) —> Arachidonic Acid —– cyclooxygenase (COX) —-> prostaglandin H2 (PGH2), which are pro-inflammation mediators